{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:58:06Z","timestamp":1764172686781,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14422-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:18:58Z","timestamp":1751354338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictive value of androgen receptor in distant metastasis of triple-negative breast cancer: a retrospective multi-center study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yiwei","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renbin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"2","key":"14422_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000351193","volume":"8","author":"N Harbeck","year":"2013","unstructured":"Harbeck N, Thomssen C, Gnant M. St. Gallen 2013: brief preliminary summary of the consensus discussion. BREAST CARE. 2013;8(2):102\u20139.","journal-title":"BREAST CARE"},{"issue":"20","key":"14422_CR2","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Metastatic behavior of breast cancer subtypes. J CLIN ONCOL. 2010;28(20):3271\u20137.","journal-title":"J CLIN ONCOL"},{"issue":"9","key":"14422_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00432-018-2697-2","volume":"144","author":"YJ Kim","year":"2018","unstructured":"Kim YJ, Kim JS, Kim IA. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database. J CANCER RES CLIN. 2018;144(9):1803\u201316.","journal-title":"J CANCER RES CLIN"},{"issue":"5","key":"14422_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s13346-018-0551-3","volume":"8","author":"S Al-Mahmood","year":"2018","unstructured":"Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. DRUG DELIV TRANSL RE. 2018;8(5):1483\u2013507.","journal-title":"DRUG DELIV TRANSL RE"},{"issue":"2","key":"14422_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.suronc.2018.03.006","volume":"27","author":"XW Qi","year":"2018","unstructured":"Qi XW, Du JZ, Tang P, Liu X, He QQ, Zhong L, Bian XW, Jiang J. Clinical significance of internal mammary lymph node metastasis for breast cancer: analysis of 337 breast cancer patients. SURG ONCOL. 2018;27(2):185\u201391.","journal-title":"SURG ONCOL"},{"key":"14422_CR6","doi-asserted-by":"crossref","unstructured":"Yao Y, Chu Y, Xu B, Hu Q, Song Q. Risk factors for distant metastasis of patients with primary triple-negative breast cancer. BIOSCIENCE REP 2019, 39(6).","DOI":"10.1042\/BSR20190288"},{"issue":"2","key":"14422_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","volume":"21","author":"J Sukumar","year":"2021","unstructured":"Sukumar J, Gast K, Quiroga D, Lustberg M, Williams N. Triple-negative breast cancer: promising prognostic biomarkers currently in development. EXPERT REV ANTICANC. 2021;21(2):135\u201348.","journal-title":"EXPERT REV ANTICANC"},{"issue":"7","key":"14422_CR8","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1158\/1078-0432.CCR-10-2021","volume":"17","author":"R Hu","year":"2011","unstructured":"Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM. Androgen receptor expression and breast cancer survival in postmenopausal women. CLIN CANCER RES. 2011;17(7):1867\u201374.","journal-title":"CLIN CANCER RES"},{"issue":"29","key":"14422_CR9","doi-asserted-by":"publisher","first-page":"46482","DOI":"10.18632\/oncotarget.10208","volume":"7","author":"C Wang","year":"2016","unstructured":"Wang C, Pan B, Zhu H, Zhou Y, Mao F, Lin Y, Xu Q, Sun Q. Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis. Oncotarget. 2016;7(29):46482\u201391.","journal-title":"Oncotarget"},{"key":"14422_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.humpath.2018.06.003","volume":"80","author":"T Zuo","year":"2018","unstructured":"Zuo T, Wilson P, Cicek AF, Harigopal M. Androgen receptor expression is a favorable prognostic factor in triple-negative breast cancers. HUM PATHOL. 2018;80:239\u201345.","journal-title":"HUM PATHOL"},{"issue":"4","key":"14422_CR11","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1016\/j.clbc.2020.01.002","volume":"20","author":"M Xu","year":"2020","unstructured":"Xu M, Yuan Y, Yan P, Jiang J, Ma P, Niu X, Ma S, Cai H, Yang K. Prognostic significance of androgen receptor expression in triple negative breast cancer: A systematic review and meta-analysis. CLIN BREAST CANCER. 2020;20(4):e385\u201396.","journal-title":"CLIN BREAST CANCER"},{"key":"14422_CR12","doi-asserted-by":"publisher","first-page":"100518","DOI":"10.1016\/j.jbo.2023.100518","volume":"44","author":"P Ilenic","year":"2024","unstructured":"Ilenic P, Herman A, Langerholc E, Gazic B, Seruga B. Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer. J BONE ONCOL. 2024;44:100518.","journal-title":"J BONE ONCOL"},{"issue":"2","key":"14422_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10585-015-9697-2","volume":"32","author":"L Gerratana","year":"2015","unstructured":"Gerratana L, Fanotto V, Bonotto M, Bolzonello S, Minisini AM, Fasola G, Puglisi F. Pattern of metastasis and outcome in patients with breast cancer. CLIN EXP METASTAS. 2015;32(2):125\u201333.","journal-title":"CLIN EXP METASTAS"},{"key":"14422_CR14","doi-asserted-by":"publisher","first-page":"978985","DOI":"10.3389\/fonc.2023.978985","volume":"13","author":"JH Fan","year":"2023","unstructured":"Fan JH, Zhang S, Yang H, Yi ZB, Ouyang QC, Yan M, Wang XJ, Hu XC, Jiang ZF, Huang T, et al. Molecular subtypes predict the Preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study. FRONT ONCOL. 2023;13:978985.","journal-title":"FRONT ONCOL"},{"issue":"1","key":"14422_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13058-024-01783-z","volume":"26","author":"X Baez-Navarro","year":"2024","unstructured":"Baez-Navarro X, van den Ende NS, Nguyen AH, Sinke R, Westenend P, van Brakel JB, Stobbe C, Westerga J, van Deurzen C. HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: are they connected? BREAST CANCER RES. 2024;26(1):41.","journal-title":"BREAST CANCER RES"},{"issue":"6","key":"14422_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/tbj.12527","volume":"21","author":"EM Der","year":"2015","unstructured":"Der EM, Gyasi RK, Tettey Y, Edusei L, Bayor MT, Jiagge E, Gyakobo M, Merajver SD, Newman LA. Triple-Negative breast Cancer in Ghanaian women: the Korle Bu teaching hospital experience. BREAST J. 2015;21(6):627\u201333.","journal-title":"BREAST J"},{"issue":"4","key":"14422_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.4103\/jcrt.jcrt_2079_21","volume":"20","author":"C He","year":"2024","unstructured":"He C, Mamuti G, Mushajiang M, Maimatiniyazi S. Risk factors and prognostic factors of brain metastasis of triple-negative breast cancer: A single-center retrospective study. J CANCER RES THER. 2024;20(4):1314\u201322.","journal-title":"J CANCER RES THER"},{"issue":"49","key":"14422_CR18","doi-asserted-by":"publisher","first-page":"e32226","DOI":"10.1097\/MD.0000000000032226","volume":"101","author":"X Yang","year":"2022","unstructured":"Yang X, Tang T, Zhou T. Prognosis and clinicopathological characteristics of metaplastic breast cancer: A meta-analysis. Medicine. 2022;101(49):e32226.","journal-title":"Medicine"},{"issue":"6","key":"14422_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/bjc.2017.224","volume":"117","author":"S Klimov","year":"2017","unstructured":"Klimov S, Rida PC, Aleskandarany MA, Green AR, Ellis IO, Janssen EA, Rakha EA, Aneja R. Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers. BRIT J CANCER. 2017;117(6):826\u201334.","journal-title":"BRIT J CANCER"},{"key":"14422_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.anndiagpath.2017.01.009","volume":"28","author":"AE Abdelrahman","year":"2017","unstructured":"Abdelrahman AE, Rashed HE, Abdelgawad M, Abdelhamid MI. Prognostic impact of EGFR and cytokeratin 5\/6 immunohistochemical expression in triple-negative breast cancer. ANN DIAGN PATHOL. 2017;28:43\u201353.","journal-title":"ANN DIAGN PATHOL"},{"issue":"3","key":"14422_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/jclinpath-2019-206078","volume":"73","author":"Y Goto","year":"2020","unstructured":"Goto Y, Thike AA, Ong C, Lim JX, Md NN, Li H, Koh V, Chen XY, Yeong J, Sasano H, et al. Characteristics, behaviour and role of biomarkers in metastatic triple-negative breast cancer. J CLIN PATHOL. 2020;73(3):147\u201353.","journal-title":"J CLIN PATHOL"},{"issue":"1","key":"14422_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1186\/s12885-022-10076-7","volume":"22","author":"Y Jeon","year":"2022","unstructured":"Jeon Y, Jo U, Hong J, Gong G, Lee HJ. Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer. BMC Cancer. 2022;22(1):1014.","journal-title":"BMC Cancer"},{"issue":"8","key":"14422_CR23","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/annonc\/mdq678","volume":"22","author":"S Park","year":"2011","unstructured":"Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW, Lee KS. Androgen receptor expression is significantly associated with better outcomes in Estrogen receptor-positive breast cancers. ANN ONCOL. 2011;22(8):1755\u201362.","journal-title":"ANN ONCOL"},{"issue":"40","key":"14422_CR24","doi-asserted-by":"publisher","first-page":"e1888130175","DOI":"10.1073\/pnas.2406837121","volume":"121","author":"S Asemota","year":"2024","unstructured":"Asemota S, Effah W, Holt J, Johnson D, Cripe L, Ponnusamy S, Thiyagarajan T, Khosrosereshki Y, Hwang DJ, He Y, et al. A molecular switch from tumor suppressor to oncogene in ER\u2009+\u2009ve breast cancer: role of androgen receptor, JAK-STAT, and lineage plasticity. P NATL ACAD SCI USA. 2024;121(40):e1888130175.","journal-title":"P NATL ACAD SCI USA"},{"issue":"2","key":"14422_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1245\/s10434-013-3260-7","volume":"21","author":"LJ McGhan","year":"2014","unstructured":"McGhan LJ, McCullough AE, Protheroe CA, Dueck AC, Lee JJ, Nunez-Nateras R, Castle EP, Gray RJ, Wasif N, Goetz MP, et al. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype. ANN SURG ONCOL. 2014;21(2):361\u20137.","journal-title":"ANN SURG ONCOL"},{"issue":"1","key":"14422_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12885-020-07218-0","volume":"20","author":"S Govindan","year":"2020","unstructured":"Govindan S, Siraganahalli EM, Basavaraj C, Adinarayan M, Sankaran S, Bakre M. Androgen receptor mRNA levels determine the prognosis in triple-negative breast cancer patients. BMC Cancer. 2020;20(1):745.","journal-title":"BMC Cancer"},{"issue":"2","key":"14422_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-2.14579","volume":"42","author":"SA Lyalkin","year":"2020","unstructured":"Lyalkin SA, Verevkina NO, Alekseyenko OO, Syvak LA. Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer. Exp Oncol. 2020;42(2):140\u20133.","journal-title":"Exp Oncol"},{"issue":"1","key":"14422_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12885-025-13832-7","volume":"25","author":"RS Bouzid","year":"2025","unstructured":"Bouzid RS, Bouzid R, Labed H, Serhani I, Hellal D, Oumeddour L, Boudhiaf I, Ibrir M, Khadraoui H, Belaaloui G. Molecular subtyping and target identification in triple negative breast cancer through immunohistochemistry biomarkers. BMC Cancer. 2025;25(1):454.","journal-title":"BMC Cancer"},{"issue":"7","key":"14422_CR29","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41379-021-00742-9","volume":"34","author":"A Bergeron","year":"2021","unstructured":"Bergeron A, MacGrogan G, Bertaut A, Ladoire S, Arveux P, Desmoulins I, Bonnefoi H, Loustalot C, Auriol S, Beltjens F, et al. Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations. Mod PATHOL. 2021;34(7):1282\u201396.","journal-title":"Mod PATHOL"},{"issue":"11","key":"14422_CR30","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","volume":"31","author":"A Khan","year":"2024","unstructured":"Khan A, Zhang Y, Ma N, Shi J, Hou Y. NF-kappaB role on tumor proliferation, migration, invasion and immune escape. CANCER GENE THER. 2024;31(11):1599\u2013610.","journal-title":"CANCER GENE THER"},{"issue":"11","key":"14422_CR31","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1016\/j.ymthe.2023.09.010","volume":"31","author":"R Sun","year":"2023","unstructured":"Sun R, Sun Y, Wu C, Liu Y, Zhou M, Dong Y, Du G, Luo H, Shi B, Jiang H, et al. CXCR4-modified CAR-T cells suppresses MDSCs recruitment via STAT3\/NF-kappaB\/SDF-1alpha axis to enhance efficacy against pancreatic cancer. MOL THER. 2023;31(11):3193\u2013209.","journal-title":"MOL THER"},{"issue":"1","key":"14422_CR32","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1530\/EO-22-0048","volume":"2","author":"K Takagi","year":"2022","unstructured":"Takagi K, Yamaguchi M, Miyashita M, Sasano H, Suzuki T. Diverse role of androgen action in human breast cancer. ENDOCR ONCOL. 2022;2(1):R102\u201311.","journal-title":"ENDOCR ONCOL"},{"issue":"3","key":"14422_CR33","doi-asserted-by":"publisher","first-page":"e353","DOI":"10.1002\/ctm2.353","volume":"11","author":"D Gong","year":"2021","unstructured":"Gong D, Sun Y, Guo C, Sheu TJ, Zhai W, Zheng J, Chang C. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis. CLIN TRANSL MED. 2021;11(3):e353.","journal-title":"CLIN TRANSL MED"},{"issue":"11","key":"14422_CR34","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1128\/MCB.00008-15","volume":"35","author":"YN Liu","year":"2015","unstructured":"Liu YN, Yin J, Barrett B, Sheppard-Tillman H, Li D, Casey OM, Fang L, Hynes PG, Ameri AH, Kelly K. Loss of androgen-regulated MicroRNA 1 activates SRC and promotes prostate cancer bone metastasis. MOL CELL BIOL. 2015;35(11):1940\u201351.","journal-title":"MOL CELL BIOL"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14422-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14422-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14422-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:19:00Z","timestamp":1751354340000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14422-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14422"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14422-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in the study and involving human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This retrospective analysis was approved by the third affiliated hospital, Sun Yat-sen University (No.[2022] 02-337-01), and informed consent was waived due to the retrospective design and no privacy leakage or expected risk to patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1115"}}